These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8053198)

  • 21. High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease.
    Schiffman K; Buckner CD; Maziarz R; Maloney DG; Appelbaum FR; Press O; Gooley T; Holmberg L; Lilleby K; Clift R; Zuckerman N; Klarnet J; Weaver C; Chauncey T; Bensinger WI
    Biol Blood Marrow Transplant; 1997 Nov; 3(5):261-6. PubMed ID: 9450921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Efficacy of rituximab-containing salvage regimens on relapsed or refractory B-cell non-Hodgkin's lymphoma].
    Huang HQ; Bu Q; Xia ZJ; Lin XB; Wang FH; Li YH; Peng YL; Pan ZH; Wang SS; Lin TY; Jiang WQ; Guan ZZ
    Ai Zheng; 2006 Apr; 25(4):486-9. PubMed ID: 16613686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Medicinal therapy of malignant lymphomas].
    Aul C; Schroeder M; Giagounidis A
    Radiologe; 2002 Dec; 42(12):943-53. PubMed ID: 12486548
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ABVD plus subtotal nodal versus involved-field radiotherapy in early-stage Hodgkin's disease: long-term results.
    Bonadonna G; Bonfante V; Viviani S; Di Russo A; Villani F; Valagussa P
    J Clin Oncol; 2004 Jul; 22(14):2835-41. PubMed ID: 15199092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of high-dose chemotherapy in patients with Hodgkin's disease and non-Hodgkin's lymphoma.
    Laport GF; Williams SF
    Semin Oncol; 1998 Aug; 25(4):503-17. PubMed ID: 9728600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. State-of-the-art therapeutics: Hodgkin's lymphoma.
    Connors JM
    J Clin Oncol; 2005 Sep; 23(26):6400-8. PubMed ID: 16155026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modality treatment in adult stage I-II Hodgkin's disease with large mediastinal masses: study of 30 cases and review of the literature.
    Grigoraki V; Lilienthal F; Touboul E; Gabarre J; Binet JL; Merle-Béral H
    Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):437-45. PubMed ID: 8414965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Questions and aspects of radiotherapy of adult patients with localized supradiaphragmatic stage (CS I/II) Hodgkin's disease. 1. Questions and aspects on indications for primary and adjuvant radiotherapy].
    Glanzmann C; Lütolf UM
    Strahlenther Onkol; 1993 Aug; 169(8):449-58. PubMed ID: 8356505
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Primary treatment of advanced Hodgkin's disease].
    Illés A; Udvardy M; Molnár Z
    Orv Hetil; 2005 Jan; 146(5):195-202. PubMed ID: 15773586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Intensive radiotherapy and polychemotherapy, clinical stage and systemic manifestations of the disease as parameters important in the prognosis for Hodgkin's disease].
    Maras J; Dubravcić M; Konstantinović M; Stula N
    Acta Med Iugosl; 1990; 44(1):35-46. PubMed ID: 2336965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes.
    Wheeler C; Eickhoff C; Elias A; Ibrahim J; Ayash L; McCauley M; Mauch P; Schwartz G; Eder JP; Mazanet R; Ferrara J; Rimm IJ; Guinan E; Bierer B; Gilliland G; Churchill WH; Ault K; Parsons S; Antman K; Schnipper L; Tepler I; Gaynes L; Frei E; Kadin M; Antin J
    Biol Blood Marrow Transplant; 1997 Jun; 3(2):98-106. PubMed ID: 9267670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dose intensification with autologous stem cell transplantation in relapsed and resistant Hodgkin's disease.
    Anselmo AP; Cavalieri E; Meloni G; Alimena G; Cantonetti M; Maurizi Enrici R; Tosti ME; Falchetto Osti M; Gianfelici V; Mandelli F
    Haematologica; 2002 May; 87(5):507-11. PubMed ID: 12010664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimens.
    Ardeshna KM; Kakouros N; Qian W; Powell MG; Saini N; D'Sa S; Mackinnon S; Hoskin PJ; Goldstone AH; Linch DC
    Br J Haematol; 2005 Aug; 130(3):363-72. PubMed ID: 16042685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hodgkin's disease.
    Longo DL; Banks PM; Hoppe RT
    Rev Invest Clin; 1994 Apr; Suppl():73-83. PubMed ID: 7886314
    [No Abstract]   [Full Text] [Related]  

  • 36. [Chemotherapy in Hodgkin's disease (author's transl)].
    Schmidt CG
    Arch Geschwulstforsch; 1978; 48(5):407-15. PubMed ID: 747513
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current strategies and new approaches in the treatment of Hodgkin's lymphoma.
    Fuchs M; Diehl V; Re D
    Pathobiology; 2006; 73(3):126-40. PubMed ID: 17085957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Lymphogranulomatosis and pregnancy].
    Gstöttner H; Hahmann K; Schmidt C; Rohrberg R; Krahl D
    Zentralbl Gynakol; 1987; 109(14):889-92. PubMed ID: 3660965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current issues in the management of advanced Hodgkin's disease.
    Bonadonna G; Santoro A
    Blood Rev; 1990 Mar; 4(1):69-73. PubMed ID: 2182149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Hodgkin's disease--change of the therapy concept?].
    Hartwich G; Sauer R
    Fortschr Med; 1981 Aug; 99(29):1113-7. PubMed ID: 7262797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.